Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/06/20
Acorda Therapeutics (ACOR) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/05/20
Acorda Therapeutics (ACOR) Flat As Market Gains: What You Should KnowZacks Investment Research • 04/16/20
Acorda Therapeutics (ACOR) Stock Moves -0.11%: What You Should KnowZacks Investment Research • 04/07/20
Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/13/20
Earnings Preview: Acorda Therapeutics (ACOR) Q4 Earnings Expected to DeclineZacks Investment Research • 02/06/20
Acorda (ACOR) Down 13.5% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 12/04/19
Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/05/19
Acorda Therapeutics (ACOR) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 10/28/19